View All Key Stats
QDEL Key Stats
| Income Statement | |
| Revenue (TTM) | 214.97M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.10 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 3.928M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 68.02% |
| Profit Margin (Quarterly) | 19.39% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 908.84M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.205 |
| PE Ratio (TTM) | 273.70 |
| Price to Book Value | 4.129 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.6619 |
| Free Cash Flow (Quarterly) | 25.86M |
| Return on Equity (TTM) | 1.95% |
View All QDEL News
QDEL News
-
WireHeadlineTime (ET)
-
Yahoo06/27 12:51
-
Business Wire06/22 18:45
-
MT Newswires06/08 06:19
-
Business Wire06/07 18:00
-
SA Breaking News05/30 15:11
-
MT Newswires05/30 14:53
-
Business Wire05/30 14:15
-
SA Breaking News05/25 07:58
-
MT Newswires05/25 04:24
-
Business Wire05/24 18:30
View All Events
QDEL Events
| Date | Type | Description |
|---|---|---|
| 05/16/2017 08:30 PDT | Misc | Quidel Corp Annual General Meeting in 2016 |
| 05/16/2017 | Misc | Quidel Completes Acquisition of Inflammadry(r) and Adenoplus(r) Eye-health Businesses |
| 04/24/2017 17:00 EDT | Misc | Quidel Corp First Quarter Earnings Conference Call in 2017 |
| 04/24/2017 | Earnings | Quidel Corp First Quarter Earnings in 2017 Release |
| 02/08/2017 14:00 PST | Misc | Quidel Corp Fourth Quarter Earnings Conference Call in 2016 |
| 02/08/2017 | Earnings | Quidel Corp Fourth Quarter Earnings in 2016 Release |
| 10/26/2016 14:00 PDT | Misc | Quidel Corp Third Quarter Earnings Conference Call in 2016 |
| 10/26/2016 | Earnings | Quidel Corp Third Quarter Earnings in 2016 Release |
| 07/27/2016 17:00 EDT | Misc | Quidel Corp Second Quarter Earnings Conference Call in 2016 |
| 07/27/2016 | Earnings | Quidel Corp Second Quarter Earnings in 2016 Release |
QDEL Fundamentals
Income Statement View Statement
QDEL Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
QDEL One Page Reports
- One Page Report Download
QDEL Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 27.37 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.quidel.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=94060&p=irol-irhome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Diagnostics & Research
- Next Earnings Release: N/A
- Last Earnings Release: Apr. 24, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Quidel Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. It includes applications in infectious diseases, women's health and gastrointestinal diseases.
QDEL Comparables
EditQDEL Excel Add-In Codes
- Name: =YCI("QDEL","name")
- Description: =YCI("QDEL","description")
- Sector: =YCI("QDEL","sector")
- Industry: =YCI("QDEL","industry")
- Est. Current Fiscal Year End: =YCI("QDEL","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other QDEL Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- QDEL Tweets Stocktwits
Advertisement
